Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma
AffiliationMedical Oncology, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractA 70-year-old man reported progressive weight loss, fatigue and a generalised rash. The rash was consistent with necrolytic migratory erythema, further investigations were performed and the patient was diagnosed with a mass in the tail of the pancreas, in keeping with a localised glucagonoma. Somatostatin analogue therapy was started for symptom control, leading to complete resolution of the skin rash and an improvement in constitutional symptoms. Subsequently, the pancreatic lesion was excised, and pathology assessment confirmed the diagnosis of well-differentiated neuroendocrine tumour with high expression of glucagon compatible with glucagonoma.
CitationSaavedra C, Lamarca A, Hubner RA. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma. BMJ Case Rep. 2019 Aug 10;12(8).
JournalBMJ Case Reports
- Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
- Authors: Wu SL, Bai JG, Xu J, Ma QY, Wu Z
- Issue date: 2014 Jul 17
- A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
- Authors: Tolliver S, Graham J, Kaffenberger BH
- Issue date: 2018 Jun
- Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
- Authors: Tremblay C, Marcil I
- Issue date: 2017 Nov/Dec
- Pancreatic glucagonoma with pancreatic calcification.
- Authors: Gupta RA, Udwadia FE, Agrawal P, Doctor N
- Issue date: 2013 May-Jun
- Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
- Authors: Jiménez-Gallo D, Ossorio-García L, de la Varga-Martínez R, Arjona-Aguilera C, Linares-Barrios M
- Issue date: 2017 Jul